Market Opportunities Report on Poorly Soluble and Poorly Permeable Drugs

Published on July 14, 2014 at 6:04 AM IN AZANO

Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI), a leading global pharmaceutical consulting firm, has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds.

http://www.azonano.com/news.aspx?newsID=30615

To download a complimentary excerpt of this report, go to:

http://www.technology-catalysts.com/pdf/psd7_bro.pdf

Source: http://www.technology-catalysts.com/

Tweet